NCT06979999

Brief Summary

This prospective interventional study will evaluate the effects of applying positive end-expiratory pressure (PEEP) at 10 cmH₂O on optic nerve sheath diameter (ONSD) in patients undergoing elective laparoscopic cholecystectomy under general anesthesia. A total of approximately 80 adult patients (ASA physical status I-III) will be included following informed consent. ONSD will be measured using a high-frequency linear ultrasound probe at three predefined intraoperative time points: (T0) 10 minutes after initiation of mechanical ventilation, (T1) 10 minutes after pneumoperitoneum creation, and (T2) 30 minutes after pneumoperitoneum creation. Dynamic lung compliance, peak airway pressure (Ppeak), end-tidal CO₂ (EtCO₂), heart rate, mean arterial pressure, and SpO₂ will also be recorded. The aim is to assess whether the application of PEEP influences intracranial pressure indicators, particularly ONSD, during laparoscopic procedures. The study may provide valuable insights into the neurophysiological effects of intra-abdominal pressure and mechanical ventilation strategies in surgical patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2024

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

April 29, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 20, 2025

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2025

Completed
Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

1.1 years

First QC Date

April 29, 2025

Last Update Submit

May 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Optic Nerve Sheath Diameter (ONSD)

    ONSD will be measured via ultrasound at 3 time points during surgery.

    Intraoperative; T0, T1, T2

Secondary Outcomes (5)

  • Change in Peak Airway Pressure (Ppeak)

    Intraoperative measurement at T0, T1, and T2

  • Change in Dynamic Lung Compliance

    Intraoperative measurement at T0, T1, and T2

  • Change in End-Tidal Carbon Dioxide (EtCO₂)

    Intraoperative measurement at T0, T1, and T2

  • Changes in Heart Rate (HR) and Mean Arterial Pressure (MAP) Time Frame

    Intraoperative measurement at T0, T1, and T2

  • Peripheral Oxygen Saturation (SpO₂)

    Intraoperative continuous monitoring and recorded at T0, T1, and T2

Study Arms (1)

PEEP Group

EXPERIMENTAL

This arm includes patients undergoing laparoscopic cholecystectomy under general anesthesia. All participants receive 10 cmH₂O PEEP after pneumoperitoneum creation, and optic nerve sheath diameter (ONSD) is measured intraoperatively at predefined time points.

Procedure: Positive End-Expiratory Pressure (PEEP)

Interventions

Application of 10 cmH₂O PEEP during mechanical ventilation after pneumoperitoneum creation in patients undergoing laparoscopic cholecystectomy.

PEEP Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Adult patients (age ≥ 18 years)
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Scheduled for elective laparoscopic cholecystectomy under general anesthesia
  • Signed informed consent

You may not qualify if:

  • resence of acute or chronic eye disease
  • Uncontrolled hypertension
  • Asthma or known chronic pulmonary disease
  • Any neurological disorders
  • Body mass index (BMI) \> 35 kg/m²
  • Use of medications known to affect intracranial pressure
  • Refusal to participate after signing informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Niğde Training and Research Hospital

Niğde, Niğde Province, 5200, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Positive-Pressure Respiration

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

April 29, 2025

First Posted

May 20, 2025

Study Start

April 29, 2024

Primary Completion

May 29, 2025

Study Completion

July 29, 2025

Last Updated

May 20, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations